1. Home
  2. DLPN vs IMNN Comparison

DLPN vs IMNN Comparison

Compare DLPN & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLPN
  • IMNN
  • Stock Information
  • Founded
  • DLPN 1996
  • IMNN 1982
  • Country
  • DLPN United States
  • IMNN United States
  • Employees
  • DLPN N/A
  • IMNN N/A
  • Industry
  • DLPN Other Consumer Services
  • IMNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • DLPN Consumer Discretionary
  • IMNN Health Care
  • Exchange
  • DLPN Nasdaq
  • IMNN Nasdaq
  • Market Cap
  • DLPN 12.6M
  • IMNN 12.1M
  • IPO Year
  • DLPN N/A
  • IMNN 1985
  • Fundamental
  • Price
  • DLPN $1.08
  • IMNN $6.53
  • Analyst Decision
  • DLPN Strong Buy
  • IMNN Buy
  • Analyst Count
  • DLPN 1
  • IMNN 2
  • Target Price
  • DLPN $5.00
  • IMNN $182.61
  • AVG Volume (30 Days)
  • DLPN 644.8K
  • IMNN 244.8K
  • Earning Date
  • DLPN 08-13-2025
  • IMNN 08-05-2025
  • Dividend Yield
  • DLPN N/A
  • IMNN N/A
  • EPS Growth
  • DLPN N/A
  • IMNN N/A
  • EPS
  • DLPN N/A
  • IMNN N/A
  • Revenue
  • DLPN $51,257,243.00
  • IMNN N/A
  • Revenue This Year
  • DLPN $6.57
  • IMNN N/A
  • Revenue Next Year
  • DLPN $18.10
  • IMNN N/A
  • P/E Ratio
  • DLPN N/A
  • IMNN N/A
  • Revenue Growth
  • DLPN 4.84
  • IMNN N/A
  • 52 Week Low
  • DLPN $0.75
  • IMNN $4.83
  • 52 Week High
  • DLPN $1.78
  • IMNN $41.22
  • Technical
  • Relative Strength Index (RSI)
  • DLPN 43.94
  • IMNN 40.89
  • Support Level
  • DLPN $0.99
  • IMNN $6.17
  • Resistance Level
  • DLPN $1.78
  • IMNN $7.21
  • Average True Range (ATR)
  • DLPN 0.11
  • IMNN 0.51
  • MACD
  • DLPN -0.01
  • IMNN 0.14
  • Stochastic Oscillator
  • DLPN 11.39
  • IMNN 20.45

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: